Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 8 months
- Director since
- 2026
8 months of board service in total across 1 board, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 8 months.
BioCryst Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,288 | $9.70 | $12,494 |
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| May 29, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,262 | $8.91 | $11,244 |
| Feb 27, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +528 | $8.75 | $4,620 |
| Jan 23, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +2,582 | — | — |
| Jan 23, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,272 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.